-
1
-
-
0027461491
-
Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam
-
Bradford, P. A., and C. C. Sanders. 1993. Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam. Antimicrob. Agents Chemother. 37:251-259.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 251-259
-
-
Bradford, P.A.1
Sanders, C.C.2
-
2
-
-
0023680397
-
Sulbactam/ampicillin in the treatment of lower respiratory infections
-
Castellano, M. A. 1988. Sulbactam/ampicillin in the treatment of lower respiratory infections. Drugs 35(Suppl. 7):53-56.
-
(1988)
Drugs
, vol.35
, Issue.7 SUPPL.
, pp. 53-56
-
-
Castellano, M.A.1
-
3
-
-
0342372866
-
Activity of ampicillin/sulbactam with simulation of human pharmacokinetics in an animal model
-
abstr. A-61, American Society for Microbiology, Washington, D.C.
-
Craig, W. A., and S. Ebert. 1995. Activity of ampicillin/sulbactam with simulation of human pharmacokinetics in an animal model, abstr. A-61, p. 12. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1995)
Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 12
-
-
Craig, W.A.1
Ebert, S.2
-
4
-
-
0018143694
-
CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: Initial bacteriological characterization
-
English, A. R., J. A. Retsema, A. E. Girard, J. E. Lynch, and W. E. Barth. 1978. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob. Agents Chemother. 14:414-419.
-
(1978)
Antimicrob. Agents Chemother.
, vol.14
, pp. 414-419
-
-
English, A.R.1
Retsema, J.A.2
Girard, A.E.3
Lynch, J.E.4
Barth, W.E.5
-
5
-
-
84960614013
-
Pharmacokinetics of sulbactam/ampicillin in humans: A review
-
Foulds, G. 1986. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev. Infect. Dis. 8(Suppl. 5):S503-S511.
-
(1986)
Rev. Infect. Dis.
, vol.8
, Issue.5 SUPPL.
-
-
Foulds, G.1
-
6
-
-
0023741422
-
Clinical experience with intramuscular sulbactam/ ampicillin in the outpatient treatment of various infections: A multicenter trial
-
Güneren, M. F. 1988. Clinical experience with intramuscular sulbactam/ ampicillin in the outpatient treatment of various infections: a multicenter trial. Drugs 35(Suppl. 7):57-68.
-
(1988)
Drugs
, vol.35
, Issue.7 SUPPL.
, pp. 57-68
-
-
Güneren, M.F.1
-
7
-
-
0025989924
-
Ampicillin-sulbactam and ticarcillin-clavulanic acid: A comparison of their in vitro activity and review of their clinical efficacy
-
Itokazu, G. S., and L. H. Danziger. 1991. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy. Pharmacotherapy 11:382-414.
-
(1991)
Pharmacotherapy
, vol.11
, pp. 382-414
-
-
Itokazu, G.S.1
Danziger, L.H.2
-
8
-
-
0030797608
-
Microbiologic and pharmacodynamic principles applied to the antimicrobial susceptibility testing of ampicillin/ sulbactam: Analysis of the correlations between in vitro test results and clinical response
-
Jones, R. N., and M. N. Dudley. 1997. Microbiologic and pharmacodynamic principles applied to the antimicrobial susceptibility testing of ampicillin/ sulbactam: analysis of the correlations between in vitro test results and clinical response. Diagn. Microbiol. Infect. Dis. 28:5-18.
-
(1997)
Diagn. Microbiol. Infect. Dis.
, vol.28
, pp. 5-18
-
-
Jones, R.N.1
Dudley, M.N.2
-
9
-
-
0024501170
-
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
-
Leggett, J. E., B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calame, H. Mattie, and W. A. Craig. 1989. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159:281-292.
-
(1989)
J. Infect. Dis.
, vol.159
, pp. 281-292
-
-
Leggett, J.E.1
Fantin, B.2
Ebert, S.3
Totsuka, K.4
Vogelman, B.5
Calame, W.6
Mattie, H.7
Craig, W.A.8
-
10
-
-
0028970115
-
Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice. Antimicrob
-
Lister, P. D., and C. C. Sanders. 1995. Comparison of ampicillin-sulbactam regimens simulating 1.5-and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice. Antimicrob. Agents Chemother. 39:930-936.
-
(1995)
Agents Chemother.
, vol.39
, pp. 930-936
-
-
Lister, P.D.1
Sanders, C.C.2
-
11
-
-
0026771139
-
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis
-
Maberry, M. C., K. J. Trimmer, R. E. Bawdon, S. Sobhi, J. B. Dax, and L. C. Gilstrap. 1992. Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis. Gynecol. Obstet. Invest. 33:185-186.
-
(1992)
Gynecol. Obstet. Invest.
, vol.33
, pp. 185-186
-
-
Maberry, M.C.1
Trimmer, K.J.2
Bawdon, R.E.3
Sobhi, S.4
Dax, J.B.5
Gilstrap, L.C.6
-
12
-
-
0345158987
-
Escherichia coli antibiotic susceptibility to ampicillin/sulbactam: Evaluation of disk diffusion, MicroScan breakpoint panel, and E test methods
-
abstr. D-44, American Society for Microbiology, Washington, D.C.
-
Martinez, O., S. Hernandez, and T. Cleary. 1996. Escherichia coli antibiotic susceptibility to ampicillin/sulbactam: evaluation of disk diffusion, MicroScan breakpoint panel, and E test methods, abstr. D-44, p. 68. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1996)
Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 68
-
-
Martinez, O.1
Hernandez, S.2
Cleary, T.3
-
13
-
-
0026452942
-
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model
-
McGrath, B. J., E. M. Bailey, K. C. Lamp, and M. J. Rybak. 1992. Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. Antimicrob. Agents Chemother. 36:2741-2746.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 2741-2746
-
-
McGrath, B.J.1
Bailey, E.M.2
Lamp, K.C.3
Rybak, M.J.4
-
15
-
-
0027312221
-
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam
-
Pfaller, M. A., A. L. Barry, P. C. Fuchs, E. H. Gerlach, D. J. Hardy, and J. C. McLaughlin. 1993. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam. Eur. J. Clin. Microbiol. Infect. Dis. 12:356-362.
-
(1993)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.12
, pp. 356-362
-
-
Pfaller, M.A.1
Barry, A.L.2
Fuchs, P.C.3
Gerlach, E.H.4
Hardy, D.J.5
McLaughlin, J.C.6
-
16
-
-
0027415020
-
Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model
-
Rice, L. B., L. L. Carias, and D. M. Shlaes. 1993. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model. Antimicrob. Agents Chemother. 37:610-612.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 610-612
-
-
Rice, L.B.1
Carias, L.L.2
Shlaes, D.M.3
-
17
-
-
0026443767
-
β-Lactam resistance in gram-negative bacteria: Global trends and clinical impact
-
Sanders, C. C., and W. E. Sanders, Jr. 1992. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
-
(1992)
Clin. Infect. Dis.
, vol.15
, pp. 824-839
-
-
Sanders, C.C.1
Sanders W.E., Jr.2
-
18
-
-
0022447993
-
The interaction of Escherichia coli with normal human serum: The kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing
-
Tesh, V. L., R. L. Duncan, Jr., and D. C. Morrison. 1986. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. J. Immunol. 137:1329-1335.
-
(1986)
J. Immunol.
, vol.137
, pp. 1329-1335
-
-
Tesh, V.L.1
Duncan R.L., Jr.2
Morrison, D.C.3
-
19
-
-
0023697158
-
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
-
Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.
-
(1988)
J. Infect. Dis.
, vol.158
, pp. 831-847
-
-
Vogelman, B.1
Gudmundsson, S.2
Leggett, J.3
Turnidge, J.4
Ebert, S.5
Craig, W.A.6
-
20
-
-
0018904866
-
Clavulanic acid and CP-45-899: A comparison of their in vitro activity in combination with penicillins
-
Wise, R., J. M. Andrews, and K. A. Bedford. 1980. Clavulanic acid and CP-45-899: a comparison of their in vitro activity in combination with penicillins. J. Antimicrob. Chemother. 6:197-206.
-
(1980)
J. Antimicrob. Chemother.
, vol.6
, pp. 197-206
-
-
Wise, R.1
Andrews, J.M.2
Bedford, K.A.3
|